|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pre-gabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial显示文摘 | ROSENSTOCK J TUCHMAN M LAMOREAUX L | 2004 | Pain2004，110，3： | 1 |
| 2 | Serin ferritin, hemoglobin, and helicobacbacter pylori infection : a seropidemiologic survey comprising 2794 danish adults 显示文摘 | MILMAN N ROSENSTOCK S ANDERSEN L | 2004 | Gastroenterology2004，115，7： | 1 |
| 3 | Basal insulin therapy in typy 2 diabates: 27 -week comparison of insulin glargine ( HOE901 ) and NPH insulin 显示文摘 | Rosenstock J Schwartz S L Clark C Jr | 2001 | Diabetes Care2001，24，11： | 1 |
| 4 | Basal insulin therapy 2 diabetes: 27 week comparison of insulin glargine (HOM901) and NPH insulin 显示文摘 | Rosenstock J Schwartz S L Clark C | 2001 | Diabetes Care2001，24，11： | 1 |
| 5 | Alogliptin added to insulin therapy in patients with type-2 diabetes reduces HbAlc without causing weight gain or increased hypoglycemia 显示文摘 | ROSENSTOCK J RENDELL M S GROSS J L | 2009 | Diabetes Obes Metab2009，11，12： | 1 |
| 6 | Serum ferritin,hemoglobin,and helicobacter pylori infection:a seroepidemiologic survey comprising 2794 danish adults显示文摘 | Milman N Rosenstock S Andersen L | 1998 | Gastroenterology1998，115，： | 1 |
| 7 | Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease显示文摘 | Rosenstock J L Gilles E Geller A B | 2010 | Int Urol Nephrol2010，42，4： | 1 |
| 8 | Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(lc), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy显示文摘 | Rosenstock J Vico M Wei L | 2012 | Diabetes Care2012，35，7： | 1 |
| 9 | Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycemia显示文摘 | Rosenstock J Rendell M S Gross J L | 2009 | Diabetes Obes Metab2009，11，12： | 1 |
| 10 | Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine (HOE 901)and NPH insulin显示文摘 | Rosenstock J Schwartz S L Clark C M | 2001 | Diabetes Care2001，24，4： | 1 |
| 11 | Serum fer- ritin,hemoglobin,and Helicobacter pylori infection:a seroepidemiologic survey comprising 2794 Danish adults 显示文摘 | Milman N Rosenstock S Andersen L | 1998 | Gastroenterology1998，115，2： | 1 |
| 12 | Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA (1C) without causing weight gain or increased hypoglycaemia 显示文摘 | Rosenstock J Rendell M S Gross J L etal | 2010 | Diabetes Obes Metab2010，11，12： | 1 |
| 13 | Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial显示文摘 | Rosenstock J Tuchman M LaMoreaux L | 2004 | Pain2004，110，3： | 1 |
| 14 | Pregabalin for the treatment of painful diabetic peripheral neuropa a double- blind, placebo-controlled trial 显示文摘 | Rosenstock J Tuchman M Moreaux L | 2005 | Pain2005，110，3： | 1 |
| 15 | Effects of dapaglifloz- in, an SGLT2 inhibitor, on HbA (1 c) , body weight, and hypo- glycemia risk in patients with type 2 diabetes inadequately con- trolled on pioglitazone monotherapy显示文摘 | ROSENSTOCK J VICO M WEI L | 2012 | Diabetes Care2012，35，7： | 1 |
| 16 | Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults显示文摘 | MILMAN N ROSENSTOCK S J ANDERSEN L | 1998 | Gastroenterology1998，115，： | 1 |
| 17 | Pregabalin for the treatment of painful diabetic peripheral neuropathy:a double-blind,placebo-controlled trial显示文摘 | Rosenstock J Tuchman M LaMoreaux L | | 0，，05： | 1 |
| 18 | Basal insulin therapy in type 2 diabetes : 28 - week comparison of insulin glargine ( HOE 901 ) and NPH insulin显示文摘 | ROSENSTOCK J SCHWARTZ S L CLARK CM Jr | 2001 | Diabetes Care2001，24，4： | 1 |
| 19 | Chronic central nervous system effects of acute organophosphate pesticide intoxication 显示文摘 | Rosenstock L Keifer M | 1991 | Lancet1991，338，： | 1 |
| 20 | Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin:a 24-week,randomized,open-label,active-controlled study(GetG oal-X)显示文摘 | Rosenstock J Raccah D Korányi L | 2013 | Diabetes Care2013，36，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员